Effect of Multiple Comorbidities on Mortality in COPD

W. Cho (SEOUL, Republic of Korea), Y. Kim (SEOUL, Republic of Korea), Y. Kim (SEOUL, Republic of Korea)

Source: Virtual Congress 2020 – COPD and the impact of comorbidities
Session: COPD and the impact of comorbidities
Session type: E-poster session
Number: 2475
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
W. Cho (SEOUL, Republic of Korea), Y. Kim (SEOUL, Republic of Korea), Y. Kim (SEOUL, Republic of Korea). Effect of Multiple Comorbidities on Mortality in COPD. 2475

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Medication Effect on Acute Exacerbation and Mortality in Patients with Coexistent COPD and GERD
Source: International Congress 2018 – COPD and extrapulmonary comorbidities
Year: 2018

Comorbidities in COPD - Impact on mortality
Source: International Congress 2018 – COPD and extrapulmonary comorbidities
Year: 2018


COPD Phenotypes and Comorbidities
Source: International Congress 2017 – COPD biomarkers
Year: 2017

30-day Readmissions After Acute Exacerbations of COPD: How Relevant Are Comorbidities?
Source: Virtual Congress 2020 – Diagnosis and management of COPD
Year: 2020


Role of Comorbidities and BMI on the Efficacy of Non Invasive Ventilation in COPD with Chronic Hypercapnia.
Source: International Congress 2018 – Non-invasive ventilation in chronic respiratory failure
Year: 2018


Frailty and Risk of COPD Readmission within 30 Days Following Exacerbation of COPD
Source: Virtual Congress 2020 – Diagnosis and management of COPD
Year: 2020

Role of comorbidities on mortality in patients hospitalized for COPD exacerbations
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014


COPD - Impact on Mortality in Locals with and without Specific Medication
Source: Virtual Congress 2021 – Lung disease burden and management
Year: 2021


Audit of Duration of Corticosteroid Treatment in Acute Exacerbations of COPD
Source: International Congress 2018 – Pharmacological management of COPD
Year: 2018


Comorbidities of COPD
Source: Eur Respir Rev 2013; 22: 454-475
Year: 2013



Comorbidities in COPD
Source: Eur Respir J 2009; 34: 1497-1498
Year: 2009


Relationship with Loss of SIGLEC14 and the Risk of COPD Exacerbation
Source: International Congress 2017 – Rare and common genetic variants of common and rare airway diseases
Year: 2017


Effects of ambient temperature on COPD symptoms and exacerbations in the SubPopulations and InteRmediate Outcome Measures In COPD Study (SPIROMICS) cohort
Source: Virtual Congress 2021 – Environment and respiratory health
Year: 2021



Outcome measures used in pulmonary rehabilitation of Acute Exacerbation of COPD
Source: International Congress 2017 – Assessing functional outcomes in respiratory physiotherapy
Year: 2017


Characteristics of essential hypertension in COPD patients
Source: International Congress 2014 – COPD: points to ponder
Year: 2014


Blood Eosinophils and Outcomes in Severe Hospitalized Exacerbations of COPD.
Source: International Congress 2017 – COPD biomarkers
Year: 2017


Cardiovascular comorbidity in COPD: Tip of iceberg
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014


Risk of cardiovascular comorbidities in patients with idiopathic pulmonary fibrosis: Analysis of Medicare data
Source: International Congress 2016 – Burden of respiratory diseases: from environmental aspects to healthcare consumption
Year: 2016


Mortality predictors in COPD exacerbation
Source: Annual Congress 2010 - COPD exacerbation
Year: 2010

Late Breaking Abstract - Arterial Stiffness and Cardiovascular Risk in hospitalised COPD patients
Source: International Congress 2019 – Imaging of airway diseases
Year: 2019